Franklin Wireless Partners to Enhance Opioid Treatment in Correctional Healthcare with Innovative Program

Innovative Opioid Treatment Program Enhances Correctional Healthcare

Armor Health, a prominent player in correctional healthcare, significantly upgrades its Medication-Assisted Treatment (MAT) and Opioid Treatment Program (OTP) through a strategic partnership with the Franklin County Sheriff's Office and Corrections Division. This enhancement introduces SUBLOCADE, a long-acting injectable (LAI) specifically formulated for adults grappling with moderate to severe opioid addiction. This initiative aims to provide effective treatment for individuals who have already begun their recovery journey with oral buprenorphine. Research highlights the efficacy of SUBLOCADE, showing that patients receiving 12 monthly injections have a marked reduction in the likelihood of opioid relapse and recidivism, thereby addressing two critical issues within the correctional system.

The program integrates a comprehensive screening process for opioid use disorder as part of the intake protocol. This ensures that individuals, whether they are entering treatment for the first time or transitioning from community-based programs, receive prompt and effective care. A pivotal component of this initiative is its focus on reentry planning, which offers structured support for individuals re-entering society. This includes "warm handoffs" to external healthcare providers, a strategy aimed at minimizing the risk of relapse and reducing the chances of reoffending. The collaborative effort reflects a broader commitment to not only treat addiction but also facilitate successful reintegration into the community, emphasizing the importance of continuity in healthcare.

Armor Health's CEO, Otto Campo, underscores the company's dedication to setting a new standard in correctional healthcare. He commends Franklin County's leadership for prioritizing innovative, evidence-based care, which not only aims to lower recidivism rates but also respects the dignity of individuals in custody. Campo believes that the implementation of SUBLOCADE LAIs represents a significant advancement, granting incarcerated patients access to high-quality healthcare comparable to that available outside correctional facilities. By leveraging proprietary analytics and partnerships, Armor Health is poised to revolutionize healthcare delivery in correctional environments, ultimately improving outcomes for a vulnerable population.

In addition to its healthcare advancements, Armor Health is enhancing its technological capabilities. The partnership with Antidot to utilize Insights Analytics demonstrates a commitment to data-driven decision-making, which can lead to more personalized and effective treatment strategies within correctional settings. This development indicates a growing recognition of the role that technology can play in improving healthcare outcomes for incarcerated individuals.

The initiative by Armor Health reflects a broader trend in the correctional healthcare industry towards more comprehensive and effective treatment programs. By focusing on evidence-based practices and innovative treatment options, Armor Health is setting a benchmark for future initiatives aimed at addressing the complex challenges of addiction and recidivism within correctional facilities.